These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 5863724)

  • 1. [The use of rifamycin SV as a method of venous perfusion in tuberculotics with liver diseases].
    Zanotelli F
    Fracastoro; 1965; 58(6):427-38. PubMed ID: 5863724
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimentation with rifamycin SV by perfusion in pulmonary tuberculosis resistant to classic therapies].
    Despierres G; Viallier J; Robillard J; Chapuy H; Perrot H
    Lyon Med; 1966 May; 215(18):1235-45. PubMed ID: 5932317
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hepato-digestive tolerance to prothionamide].
    Lesorbre R; Delacoux E; Frey N; Wilmotte F; Legrand M
    Ann Biol Clin (Paris); 1968; 26(5):681-8. PubMed ID: 5681857
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tuberculosis and liver diseases].
    Wildhirt E
    Med Klin; 1965 Jul; 60(27):1065-9. PubMed ID: 5835050
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biliary elimination of rifamycin SV in perfusions of isolated swine liver].
    Chevrel JP; Opolon P; Hadchouel P
    Presse Med (1893); 1969 Apr; 77(19):721-2. PubMed ID: 5796029
    [No Abstract]   [Full Text] [Related]  

  • 6. [The influence of therapeutical and biological parameters on the appearance of side effects and complaints during intermittent chemotherapy of pulmonary tuberculosis (author's transl)].
    Eule H; Iwainsky H
    Prax Klin Pneumol; 1981 Aug; 35(8):347-53. PubMed ID: 7345430
    [No Abstract]   [Full Text] [Related]  

  • 7. [Rifamycin SV in the therapy of tuberculosis].
    Covacev L; Monzali G
    Clin Ter; 1966 Dec; 39(6):547-66. PubMed ID: 5999285
    [No Abstract]   [Full Text] [Related]  

  • 8. [Considerations on the clinical use of rifamycin M 14].
    Idéo G
    Clin Ter; 1966 Apr; 37(1):35-45. PubMed ID: 5919307
    [No Abstract]   [Full Text] [Related]  

  • 9. Rifamycin SV clearance as hepatic functional test. Comparison with the bromsulphalein clearance.
    Laudano OM; Cifarelli C; Brasca A; Mercol E
    Rev Int Hepatol; 1967; 17(5):423-8. PubMed ID: 6056143
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of rifamycin SV in the local treatment of pulmonary tuberculosis in resistant or initially severe cases].
    Tricoire J; Yannicopoulos MC
    Rev Tuberc Pneumol (Paris); 1965 Dec; 29(12):1071-6. PubMed ID: 5865572
    [No Abstract]   [Full Text] [Related]  

  • 11. Rifapentine--a long-acting rifamycin for tuberculosis.
    Med Lett Drugs Ther; 1999 Feb; 41(1047):21-2. PubMed ID: 10076594
    [No Abstract]   [Full Text] [Related]  

  • 12. A retrospective evaluation of completion rates, total cost, and adverse effects for treatment of latent tuberculosis infection in a public health clinic in central massachusetts.
    Young H; Wessolossky M; Ellis J; Kaminski M; Daly JS
    Clin Infect Dis; 2009 Aug; 49(3):424-7. PubMed ID: 19548835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary report on the clinical trial of a new antibiotic--Rifocin (rifamycin sv).
    Amaku EO
    West Afr Med J Niger Pract; 1968 Dec; 17(6):281-2 passim. PubMed ID: 4883474
    [No Abstract]   [Full Text] [Related]  

  • 14. [The rifomycins in pneumo-phthisiologic therapy].
    Tacquet A; Devulder B; Lelievre G
    Mars Med; 1966; 103(11):827-37. PubMed ID: 5991815
    [No Abstract]   [Full Text] [Related]  

  • 15. [The significance of the liver for the diagnosis and therapy of lung diseases].
    Markoff N
    Bibl Tuberc; 1965; 20():71-98. PubMed ID: 5877569
    [No Abstract]   [Full Text] [Related]  

  • 16. Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2.
    Fattinger K; Cattori V; Hagenbuch B; Meier PJ; Stieger B
    Hepatology; 2000 Jul; 32(1):82-6. PubMed ID: 10869292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worsening of steroid depending bronchial asthma following rifampicin administration.
    Dhanoa J; Natu M; Massey S
    J Assoc Physicians India; 1998 Feb; 46(2):242. PubMed ID: 11273129
    [No Abstract]   [Full Text] [Related]  

  • 18. Rifamycin SV (Rifocin 500) clearance as a hepatic function test.
    Laudano OM; Brasca A
    Farmaco Prat; 1974 Jun; 29(6):347-50. PubMed ID: 4840110
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety of the rifampin and pyrazinamide short-course regimen for treating latent tuberculosis infection.
    Ijaz K; McElroy PD; Jereb J; Navin TR; Castro KG
    Clin Infect Dis; 2007 Feb; 44(3):464-5; author reply 465. PubMed ID: 17205462
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the passage into the anterior chamber of rifamycin SV administered by venous perfusion].
    Milano C
    Boll Soc Ital Biol Sper; 1966 Feb; 42(3):102-4. PubMed ID: 5945185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.